BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24114865)

  • 1. Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure.
    Gaggin HK; Motiwala S; Bhardwaj A; Parks KA; Januzzi JL
    Circ Heart Fail; 2013 Nov; 6(6):1206-13. PubMed ID: 24114865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction.
    Huang WP; Zheng X; He L; Su X; Liu CW; Wu MX
    Chin Med J (Engl); 2018 Jun; 131(11):1282-1288. PubMed ID: 29786039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
    Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
    J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel.
    Januzzi JL; Pascual-Figal D; Daniels LB
    Am J Cardiol; 2015 Apr; 115(7 Suppl):70B-5B. PubMed ID: 25670638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Snider J; Cohn JN
    Circ Heart Fail; 2014 May; 7(3):418-26. PubMed ID: 24622243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.
    Manzano-Fernández S; Mueller T; Pascual-Figal D; Truong QA; Januzzi JL
    Am J Cardiol; 2011 Jan; 107(2):259-67. PubMed ID: 21211603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
    Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
    JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
    Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
    Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
    Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
    Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
    Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
    Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
    Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
    Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
    Broch K; Andreassen AK; Ueland T; Michelsen AE; Stueflotten W; Aukrust P; Aakhus S; Gullestad L
    Int J Cardiol; 2015 Jan; 179():378-84. PubMed ID: 25464491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
    Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
    JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
    Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
    PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
    Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
    J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
    Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results.
    Wu AH; Wians F; Jaffe A
    Am Heart J; 2013 Jun; 165(6):995-9. PubMed ID: 23708172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Ibrahim NE; Januzzi JL; Rabideau DJ; Gandhi PU; Gaggin HK
    Am J Cardiol; 2017 Sep; 120(5):803-808. PubMed ID: 28728744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.